Angina is chest pain or a feeling of pressure that occurs when the heart does not receive enough blood or oxygen. The standard treatment approach includes medication, lifestyle changes, and, when needed, interventional methods such as angioplasty or bypass surgery. In some patients, however, symptoms persist despite these treatments, or the patient may not be a suitable candidate for an interventional procedure — this is where EECP is considered as a non-surgical option.
Cuffs on the legs inflate and deflate in sync with the heartbeat, timed to the cardiac cycle.
Aims to increase the amount of blood reaching the coronary circulation while the heart is at rest.
Helps reduce the workload placed on the heart during each cycle.
IEPR data have reported improvement in angina severity classification (CCS class) in a significant proportion of patients after treatment.
ACC/AHA guidelines classify EECP as a Class IIb recommendation (Level of Evidence B) for treatment-resistant angina.
This classification means EECP may be considered in certain patient groups but is not a first-line treatment.
In the MUST-EECP trial, patients with stable angina receiving active EECP had a longer time to exercise-induced ischemia.
The same trial reported a reduced frequency of angina attacks among patients receiving active treatment.
Patients with stable angina whose symptoms are not fully controlled by standard treatment.
Patients with refractory angina that does not respond adequately to standard treatments.
Patients with treatment-resistant angina who are not suitable candidates for revascularization.
Important: If you experience sudden, severe chest pain, this could be a sign of unstable angina — seek emergency medical care immediately. This content is for general informational purposes only and is not a substitute for medical advice; if you are experiencing angina, please consult a cardiologist to discuss whether EECP may be an appropriate option for you.